Cerus Corporation (CERS) Financials

CERS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 197.7 million 144.3 million
2023-09-30 205.8 million 156.8 million
2023-06-30 198.9 million 147.2 million
2023-03-31 209.3 million 149.8 million

CERS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -15.0 million 4.9 million
2023-09-30 -13.1 million 4.0 million
2023-06-30 -9.4 million 5.7 million
2023-03-31 -10.0 million 5.7 million

CERS Net Income

No data available :(

CERS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 65.9 million - 16.2 million
2023-09-30 79.0 million - 16.4 million
2023-06-30 84.5 million - 16.6 million
2023-03-31 94.7 million 54.8 million 17.1 million

CERS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 181.2 million
2023-09-30 180.9 million
2023-06-30 180.6 million
2023-03-31 178.3 million

CERS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 6000 13.6 million 17.3 million -
2023-09-30 2.6 million 16.8 million 16.2 million -
2023-06-30 444000 19.2 million 20.5 million -
2023-03-31 1.5 million 17.4 million 21.6 million -

CERS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 46.8 million 21.5 million
2023-09-30 39.8 million 18.0 million
2023-06-30 38.9 million 17.5 million
2023-03-31 31.0 million 13.7 million

CERS

Price: $1.71

52 week price:
1.21
3.08

Earnings Per Share: -0.22 USD

P/E Ratio: -8.78

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Volume: 1.8 million

Ebitda: -11.8 million

Market Capitalization: 317.2 million

Links: